| 000 | 01706 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518071756.0 | ||
| 264 | 0 | _c20201023 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2019.118718 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yang | |
| 245 | 0 | 0 |
_aA facile di-acid mono-amidation strategy to prepare cyclization-activating mono-carboxylate transporter 1-targeting gemcitabine prodrugs for enhanced oral delivery. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cJan 2020 |
||
| 300 |
_a118718 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 | _aCyclization |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 |
_aMonocarboxylic Acid Transporters _xmetabolism |
| 650 | 0 | 4 | _aProdrugs |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSymporters _xmetabolism |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aWang, Gang | |
| 700 | 1 | _aChen, Hongxiang | |
| 700 | 1 | _aSun, Yixin | |
| 700 | 1 | _aSun, Mengchi | |
| 700 | 1 | _aLiu, Xiaohong | |
| 700 | 1 | _aJian, Wang | |
| 700 | 1 | _aHe, Zhonggui | |
| 700 | 1 | _aSun, Jin | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 573 _gp. 118718 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2019.118718 _zAvailable from publisher's website |
| 999 |
_c30341476 _d30341476 |
||